A Multigene Test Could Cost|Effectively Help Extend Life ...

A Multigene Test Could Cost-Effectively Help Extend Life ... - PubMed

Testing seven breast cancer-associated genes, followed by risk-reduction management, could cost-effectively improve life expectancy for women at risk of ...

A Multigene Test Could Cost-Effectively Help Extend Life ...

Testing seven breast cancer–associated genes, followed by risk-reduction management, could cost-effectively improve life expectancy for women at risk of ...

A multigene test could cost-effectively help extend life expectancy for ...

A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer—Reply to letter to the editor by Petelin et al ...

A multigene test could cost-effectively help extend life expectancy for ...

A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer-Reply to letter to the editor by Petelin ...

[PDF] A Multigene Test Could Cost-Effectively Help Extend Life ...

Semantic Scholar extracted view of "A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.

A Multigene Test Could Cost-Effectively Help Extend Life ...

A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer. Li Y 1 ,. Arellano AR 1 ,. Bare LA 1 ...

For Women at Risk of Hereditary Breast Cancer, Multigene Test ...

The report of these findings, A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer, was published ...

A Multigene Test Could Cost-Effectively Help Extend Life ...

Download Citation | A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer | Background: The ...

A Multigene Test Could Cost-Effectively Help Extend Life ... - Matilda

Matilda - A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.

Multigene Testing of Everyone Diagnosed With Breast Cancer ...

A study found testing all people diagnosed with breast cancer for mutations in three genes linked to a high risk of the disease (BRCA1, ...

Cost-Effectiveness of Multigene Testing for Breast and Ovarian Cancer

Population-wide genetic testing was 100% cost-effective for all the simulations in probabilistic sensitivity analyses; it became cost- ...

893 - Value in Health

A multigene test could cost-effectively · help extend life expectancy for women at risk of hereditary breast · cancer. Value Health 2017;20:547–55. [3] LaDuca H ...

A multigene test could cost-effectively help extend life expectancy for ...

A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer-Reply to letter to the editor by Petelin et al.

Cost-effectiveness of Multigene Testing for All Patients With Breast ...

One year's unselected panel genetic testing could prevent 2101 cases of breast or ovarian cancer and 633 deaths in the United Kingdom and 9733 ...

All Women with Breast Cancer Should Undergo Multigene Testing ...

Multigene testing for all woman diagnosed with breast cancer can be “extremely cost-effective” compared to testing based on family history ...

A Multigene Test Could Cost-Effectively Help Extend Life ...

A Multigene Test Could Cost-Effectively Help Extend Life. Expectancy for Women at Risk of Hereditary Breast Cancer. Yonghong Li, PhD*, Andre R. Arellano, BS ...

Multigene Testing Offers Cost-Effectiveness, Broader Approach to ...

A large US study showed population-based multigene testing might be a cost-effective way to identify women at risk for breast and ovarian cancer.

Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal ...

Li et al. A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer. Value Health. (2017). L.J. ...

Population Genomic Screening for Three Common Hereditary ...

A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer. Value Health. 2017;20:547 ...

A review of the cost-effectiveness of genetic testing for germline ...

A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer. Value Health. 2017;20(4):547–555. (Open ...